ARTICLE | Clinical News
Uniprost regulatory update
November 6, 2000 8:00 AM UTC
The FDA accepted for filing UTHR's NDA for its Uniprost subcutaneous modified prostacyclin to treat pulmonary arterial hypertension. The NDA, which was submitted in October, has priority review design...